The Future of Pet Parenthood is Now

$150+ Billion Market Spent on pets, and growing

Pet parents increasingly view pets as family and they’re spending like it. The pet market is one of the fastest-growing consumer segments in the US, with no ceiling in sight.

Driven by humanization trends, we’re looking at a market transformation with no signs of slowing.

US househods have a pet
2 Out of 0
of pet parents consider pets part of the family
0 %
of Millennials prefer pets over children
0 %
of owners will reduce spend in other categories for a sick pet
0 %
Annual growth trends over the past decade
0 %
Projected market expansion in the coming decade
0 x

Pet Health: The Fastest-Growing
Segment

Pet parents spend more than ever, yet veterinary medicine is years behind human medicine. With a first-mover advantage, OKAVA is positioned to capture a multibillion-dollar white space and define the future of pet health.

Corporate Deck
Investor Inquiries
Valuation of Growth of Top 10 Animal Health Companies
0 x
Emergence of Blockbuster Pet Medicines
$ 0 B

OKAVA targets conditions affecting millions of pets obesity, diabetes, arthritis, and chronic inflammation where current options don’t exist or fall short.

We fill this gap with transformational solutions that deliver outsized returns.

Pet Pharma Arbitrage: Human-Scale Returns at a Fraction of the Risk, Time, and Cost

Risk adjusted R&D costs to commercialization
$ 0 Million
Product Revenue Potential
$ 0 + Billion

I spent decades in human BioPharma navigating headwinds at every turn pricing pressures, regulatory hurdles, market saturation. Pet health is the complete opposite. In pet, we have double digit growth, passionate customers willing to pay premium prices, and a massive innovation gap waiting to be filled.”

– Michael Klotsman, PhD, MPH, MBA | Founder & CEO of OKAVA

Pet Pharma Arbitrage
Investor Inquiries